ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 120 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $127,115 | -18.9% | 62,618 | -8.1% | 0.00% | – |
| Q2 2023 | $156,784 | +41.1% | 68,167 | +85.9% | 0.00% | – |
| Q1 2023 | $111,095 | +104.7% | 36,665 | +57.4% | 0.00% | – |
| Q4 2022 | $54,263 | +1256.6% | 23,289 | +1694.2% | 0.00% | – |
| Q1 2022 | $4,000 | -97.0% | 1,298 | -96.2% | 0.00% | – |
| Q4 2021 | $132,000 | -30.2% | 34,108 | -45.3% | 0.00% | – |
| Q2 2021 | $189,000 | -22.5% | 62,310 | -14.8% | 0.00% | – |
| Q1 2021 | $244,000 | +281.2% | 73,115 | +307.9% | 0.00% | – |
| Q4 2020 | $64,000 | +190.9% | 17,926 | +155.6% | 0.00% | – |
| Q3 2020 | $22,000 | -96.3% | 7,013 | -97.8% | 0.00% | – |
| Q2 2020 | $590,000 | +57.8% | 324,292 | -12.4% | 0.00% | – |
| Q1 2020 | $374,000 | -44.7% | 370,148 | +52.2% | 0.00% | – |
| Q4 2019 | $676,000 | +138.0% | 243,218 | +30.7% | 0.00% | – |
| Q3 2019 | $284,000 | -17.9% | 186,124 | +11.8% | 0.00% | – |
| Q2 2019 | $346,000 | +1547.6% | 166,409 | +2789.5% | 0.00% | – |
| Q1 2019 | $21,000 | +16.7% | 5,759 | +25.1% | 0.00% | – |
| Q4 2018 | $18,000 | +38.5% | 4,605 | +232.0% | 0.00% | – |
| Q3 2018 | $13,000 | -95.3% | 1,387 | -96.3% | 0.00% | – |
| Q2 2018 | $276,000 | +31.4% | 37,762 | -10.0% | 0.00% | – |
| Q1 2018 | $210,000 | -6.2% | 41,965 | -5.4% | 0.00% | – |
| Q4 2017 | $224,000 | -31.3% | 44,361 | -15.6% | 0.00% | – |
| Q3 2017 | $326,000 | – | 52,566 | +45609.6% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 115 | -93.8% | 0.00% | – |
| Q1 2017 | $6,000 | -68.4% | 1,854 | -66.3% | 0.00% | – |
| Q3 2016 | $19,000 | -9.5% | 5,500 | -9.5% | 0.00% | – |
| Q2 2016 | $21,000 | -12.5% | 6,078 | +6.0% | 0.00% | – |
| Q1 2016 | $24,000 | -31.4% | 5,733 | -28.9% | 0.00% | – |
| Q4 2015 | $35,000 | -23.9% | 8,059 | +7.3% | 0.00% | – |
| Q3 2015 | $46,000 | – | 7,512 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 260,000 | $866,000 | 0.34% |
| RTW INVESTMENTS, LP | 5,978,355 | $19,908,000 | 0.31% |
| GSA CAPITAL PARTNERS LLP | 309,839 | $1,032,000 | 0.17% |
| QCM Cayman, Ltd. | 12,728 | $42,000 | 0.13% |
| COWEN AND COMPANY, LLC | 486,717 | $1,621,000 | 0.11% |
| Hudson Bay Capital Management LP | 1,400,000 | $4,662,000 | 0.06% |
| Kerrisdale Advisers, LLC | 208,150 | $693,000 | 0.05% |
| Secure Asset Management, LLC | 10,000 | $33,000 | 0.02% |
| PDT Partners, LLC | 72,500 | $241,000 | 0.02% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,000 | $43,000 | 0.02% |